Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hideki Tani

Showing results (71-80 of 114) with videos related to

Pageof 12
Sort By:
Viruses|July 2, 2021
M Segment-Based Minigenome System of Severe Fever with Thrombocytopenia Syndrome Virus as a Tool for Antiviral Drug ScreeningHiroshi Yamada, Satoshi Taniguchi, Masayuki Shimojima, et al.
Cureus|March 18, 2025
Successful 30-Day Nirmatrelvir/Ritonavir Treatment of a Patient Who Developed Multi-relapsed COVID-19 After Receiving R-CHOP Against Follicular LymphomaKou Kimoto, Hitoshi Kawasuji, Yoshihiro Yoshida, et al.
Frontiers in Immunology|May 2, 2024
High interleukin-6 levels induced by COVID-19 pneumonia correlate with increased circulating follicular helper T cell frequency and strong neutralization antibody response in the acute phase of Omicron breakthrough infectionHitoshi Kawasuji, Yoshitomo Morinaga, Kentaro Nagaoka, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|October 27, 2014
Development and validation of serological assays for viral hemorrhagic fevers and determination of the prevalence of Rift Valley fever in Borno State, NigeriaDavid Nadeba Bukbuk, Shuetsu Fukushi, Hideki Tani, et al.
Japanese Journal of Infectious Diseases|November 30, 2025
Genome epidemiological and seroepidemiological study of the COVID-19 cluster in the nursing homeKei Fukuyama, Kinuko Kamiyoshi, Masae Itamochi, et al.
Viruses|August 26, 2022
Neutralizing mAbs against SFTS Virus Gn Protein Show Strong Therapeutic Effects in an SFTS Animal ModelMasayuki Shimojima, Satoko Sugimoto, Kunihiko Umekita, et al.
Japanese Journal of Infectious Diseases|May 31, 2023
Neutralizing Antibody Levels and Epidemiological Characteristics of Patients with Breakthrough COVID-19 Infection in Toyama, JapanHideki Tani, Noriko Inasaki, Shunsuke Yazawa, et al.
Journal of Virology|August 28, 2003
In vitro and in vivo gene delivery by recombinant baculovirusesHideki Tani, Chang Kwang Limn, Chan Choo Yap, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|January 27, 2017
Retrospective survey of severe fever with thrombocytopenia syndrome in patients with suspected rickettsiosis in JapanMasaaki Satoh, Shintaro Akashi, Motohiko Ogawa, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|June 12, 2022
Effectiveness of the third dose of BNT162b2 vaccine on neutralizing Omicron variant in the Japanese populationHitoshi Kawasuji, Yoshitomo Morinaga, Hideki Tani, et al.
Pageof 12

Showing results (71-80 of 114) with videos related to

Sort By:
Pageof 12
Viruses|July 2, 2021
M Segment-Based Minigenome System of Severe Fever with Thrombocytopenia Syndrome Virus as a Tool for Antiviral Drug ScreeningHiroshi Yamada, Satoshi Taniguchi, Masayuki Shimojima, et al.
Cureus|March 18, 2025
Successful 30-Day Nirmatrelvir/Ritonavir Treatment of a Patient Who Developed Multi-relapsed COVID-19 After Receiving R-CHOP Against Follicular LymphomaKou Kimoto, Hitoshi Kawasuji, Yoshihiro Yoshida, et al.
Frontiers in Immunology|May 2, 2024
High interleukin-6 levels induced by COVID-19 pneumonia correlate with increased circulating follicular helper T cell frequency and strong neutralization antibody response in the acute phase of Omicron breakthrough infectionHitoshi Kawasuji, Yoshitomo Morinaga, Kentaro Nagaoka, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|October 27, 2014
Development and validation of serological assays for viral hemorrhagic fevers and determination of the prevalence of Rift Valley fever in Borno State, NigeriaDavid Nadeba Bukbuk, Shuetsu Fukushi, Hideki Tani, et al.
Japanese Journal of Infectious Diseases|November 30, 2025
Genome epidemiological and seroepidemiological study of the COVID-19 cluster in the nursing homeKei Fukuyama, Kinuko Kamiyoshi, Masae Itamochi, et al.
Viruses|August 26, 2022
Neutralizing mAbs against SFTS Virus Gn Protein Show Strong Therapeutic Effects in an SFTS Animal ModelMasayuki Shimojima, Satoko Sugimoto, Kunihiko Umekita, et al.
Japanese Journal of Infectious Diseases|May 31, 2023
Neutralizing Antibody Levels and Epidemiological Characteristics of Patients with Breakthrough COVID-19 Infection in Toyama, JapanHideki Tani, Noriko Inasaki, Shunsuke Yazawa, et al.
Journal of Virology|August 28, 2003
In vitro and in vivo gene delivery by recombinant baculovirusesHideki Tani, Chang Kwang Limn, Chan Choo Yap, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|January 27, 2017
Retrospective survey of severe fever with thrombocytopenia syndrome in patients with suspected rickettsiosis in JapanMasaaki Satoh, Shintaro Akashi, Motohiko Ogawa, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|June 12, 2022
Effectiveness of the third dose of BNT162b2 vaccine on neutralizing Omicron variant in the Japanese populationHitoshi Kawasuji, Yoshitomo Morinaga, Hideki Tani, et al.
Pageof 12